
IV salbutamol effectively treats severe acute asthma (SAA) in children without requiring Pediatric Intensive Care Unit (PICU) transfer in 46% of cases. A Dutch multicenter study (2021–2023) analyzed 103 children with 112 SAA episodes. Adverse events occurred in 61%, though no intubations or deaths were reported. Findings support IV salbutamol use in pediatric medium-care settings, reducing PICU admissions.
Like
Save
Share